Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $62,954.98 +0.32%
  • Ethereum $1,878.14 +0.30%
  • BNB $611.05 +0.64%
  • Optimism $0.09 +0.61%
  • Arbitrum $0.07 -0.12%
  • Solana $75.14 -0.35%
  • Polygon $0.22 +2.77%
  • Cosmos $1.49 -3.83%
  • Avalanche $6.58 +3.56%
  • Bitcoin $62,954.98 +0.32%
  • Ethereum $1,878.14 +0.30%
  • BNB $611.05 +0.64%
  • Optimism $0.09 +0.61%
  • Arbitrum $0.07 -0.12%
  • Solana $75.14 -0.35%
  • Polygon $0.22 +2.77%
  • Cosmos $1.49 -3.83%
  • Avalanche $6.58 +3.56%
Home / Neumora Therapeutics / investors

Neumora Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
3
17
Neumora Therapeutics is funded by 17 investors. Mubadala Capital Ventures and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Mubadala Capital Ventures Yes Series B
ARCH Venture Partners - Series B
Abu Dhabi Growth Fund - Series B
Altitude Life Science Ventures - Series B
Amgen - Series B
EXOR N.V. - Series B
F-Prime Capital - Series B
Invus - Series B
Newpath Management - Series B
Polaris Partners - Series B
Alexandria Venture Investments - Series A
Catalio Capital Management - Series A
Logos Capital - Series A
re.Mind Capital - Series A
SoftBank Vision Fund - Series A
Surveyor Capital - Series A
Waycross Ventures - Series A

Contact

Watertown,Massachusetts,United States
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions